AURKA and gastrointestinal stromal tumor: As shown in Fig. 3C, patients with GIST with elevated AURKA expression exhibited poorer DFS than those with low AURKA expression levels (43.25 ± 6.94 months vs. 98.48 ± 3.44 months, P < 0.001).